Small RNA sequencing of whole blood from a rat model of chronic primary pain with adrenergic receptor blockade
Ontology highlight
ABSTRACT: The sympathetic nervous system has been implicated in the development of chronic primary pain conditions (CPPCs), yet the downstream molecular mechanisms linking sustained catecholamine signaling to chronic pain remain poorly understood. Here, we profiled circulating small RNAs in a rat model of CPPC induced by sustained catecholamine elevation through catechol-O-methyltransferase (COMT) inhibition. Female Sprague-Dawley rats (N = 5/group) were assigned to four treatment groups: Vehicle + Vehicle (pain-free control), OR486 + Vehicle (primary pain condition), Vehicle + ICI-118,551/SR59230A, or OR486 + ICI-118,551/SR59230A. OR486 and vehicle were delivered continuously for 14 days by subcutaneous osmotic minipump. Separate minipumps delivered the ADRB2-selective antagonist ICI-118,551 and the ADRB3-selective antagonist SR59230A or vehicle. Whole blood was collected on Day 14 for small RNA isolation and Illumina small RNA sequencing. Differential expression analysis identified a discrete set of circulating miRNAs altered during primary pain, including significant downregulation of miR-133a-3p and upregulation of multiple inflammation-associated miRNAs. Pharmacologic blockade of ADRB2/3 prevented miR-133a-3p downregulation, identifying miR-133a-3p as an adrenergic receptor-dependent regulator associated with chronic primary pain.
ORGANISM(S): Rattus norvegicus
PROVIDER: GSE338452 | GEO | 2026/07/13
REPOSITORIES: GEO
ACCESS DATA